ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,042,000 | -13.0% | 50,000 | 0.0% | 0.59% | -11.0% |
Q2 2023 | $1,197,500 | +27.3% | 50,000 | 0.0% | 0.66% | +2.3% |
Q1 2023 | $941,000 | +18.2% | 50,000 | 0.0% | 0.65% | -17.4% |
Q4 2022 | $796,000 | -33.8% | 50,000 | -2.9% | 0.79% | +124.6% |
Q4 2021 | $1,202,000 | -1.6% | 51,500 | -29.9% | 0.35% | +12.9% |
Q3 2021 | $1,221,000 | +271.1% | 73,500 | +444.4% | 0.31% | +248.3% |
Q2 2021 | $329,000 | +161.1% | 13,500 | +474.5% | 0.09% | +67.9% |
Q4 2020 | $126,000 | -3.1% | 2,350 | -25.4% | 0.05% | -15.9% |
Q3 2020 | $130,000 | – | 3,150 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |